BPIQ Blog

Jul 15, 20181 min read

TBPH To Report On nOH Results For TD-9855 This Month - Medium Risk And Reward

Summary TBPH reporting TD-9855 data in nOH by end of July Medium risk and reward opportunity TBPH July data for wholly owned TD-9855...

Jul 1, 20181 min read

ZGNX imminently releasing more Ph3 data in a severe form of childhood epilepsy

Zogenix (ZGNX) is set to imminently release additional phase 3 data from its trial with its drug ZX008 (low dose fenfluramine) for...

Jun 23, 20181 min read

GBT's Part A Phase 3 Sickle Cell Data - Any Day Now

Looking forward to Global Blood Therapeutics report out of Part A from their Phase 3 Hope study of their drug voxelotor (formerly GBT440)...

Jump start your biotech due diligence

Our platform helps you uncover your next biotech investment opportunity